Aimei Health Technology Co., Ltd stands at the forefront of healthcare innovation, harnessing artificial intelligence to revolutionize patient care with cutting-edge diagnostics and treatment solutions. With a strategic emphasis on improving operational efficiencies across healthcare systems, the company is well-positioned to thrive in a dynamic market propelled by surging demand for digital health solutions. Aimei's dedication to developing next-generation products focused on enhancing patient outcomes highlights its strong potential for sustainable growth, establishing it as an attractive investment opportunity for institutional investors aiming to engage with the transformative trends in health technology.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -1.04% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.56 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -30.20% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $4.40M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently contracting